+ Larger Font | - Smaller Font
Share


Sorry, Your Requested Page Was Not Found.
Greetings! We apologize for the inconvenience, but the page, Scientific News Axonics Gains After Boston Scientific Says It Will End Use Of Coaptite On Nov 1 is no longer available. Please use our search box below to find related content and browse the list of related news stories. Depending on the topic, news articles are deleted 3 - 18 months after the created date. We prefer to keep content fresh and current and not keep old news. Thanks for visiting today.
Search RobinsPost News & Noticias


Scientific News Axonics Gains After Boston Scientific Says It Will End Use Of Coaptite On Nov 1 | RobinsPost News & Noticias

Axonics gains after Boston Scientific says it will end use of Coaptite on Nov. 1


Axonics (NASDAQ:AXNX) quickly rose 1% after Boston Scientific (BSX) said it will no longer offer Coaptite as of Nov. 1. Investors believe the announcement may mean that Boston Scientific (BSX ... Read More

Axonics gains after Nasdaq delisting notice for sale to Boston Scientific


Investors were waiting for news about the close of the deal after Axonics (AXNX) and Boston Scientific (BSX) announced in April that they received a second request from the FTC. Boston Scientific ... Read More

Boston Scientific Stock Set to Gain From Completion of Axonics Deal


Boston Scientific Corporation BSX recently closed the acquisition of Axonics, Inc., a medical ... and acquisition-related charges. After the Nov. 15 announcement, shares of BSX jumped 3.3% ... Read More

Boston Scientific stock holds rating after Axonics acquisition


On Wednesday, Boston Scientific Corporation (NYSE:BSX) maintained its Hold rating by a prominent financial firm following the recent completion of its acquisition of Axonics. The transaction ... Read More

Boston Scientific Closes Acquisition of Axonics, Inc.


Nov. 15, 2024 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced the close of its acquisition of Axonics ... contained in this document. 1 Equity value based on total ... Read More

Boston Scientific Completes $3.7B Acquisition of Axonics


Axonics devices are implanted to help control incontinence and can last as long as 17 to 24 years or more Boston Scientific Corp. (NYSE ... at $70.98 and a $3.6 billion market cap on Nov. 15 the day ... Read More

Boston Scientific closes acquisition of Axonics


Boston Scientific (BSX) announced the close of its acquisition of Axonics (AXNX). The purchase price of $71 cash per share represents an equity value of $3.7B and an enterprise value of $3.3B. Read More

Boston Scientific stock holds rating after Axonics acquisition


On Wednesday, Boston Scientific Corporation (NYSE:BSX) maintained its Hold rating by a prominent financial firm following the recent completion of its acquisition of Axonics ... In other recent news, ... Read More

Boston Scientific Closes Acquisition of Axonics, Inc.


MARLBOROUGH, Mass., Nov. 15, 2024 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced the close of its acquisition of Axonics, Inc. (Nasdaq: AXNX), a medical technology ... Read More


Blow Us A Whistle


Comments (Whistles) Designed By Disqus